Report Detail

Pharma & Healthcare Global Cystic Fibrosis Drugs Sales Market Report 2019

  • RnM2786382
  • |
  • 22 January, 2019
  • |
  • Global
  • |
  • 126 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Cystic Fibrosis Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report studies the global Cystic Fibrosis Drugs market status and forecast, categorizes the global Cystic Fibrosis Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Major manufacturers covered in this report
Actavis
F. Hoffmann-La Roche
Gilead Sciences
Novartis
Vertex Pharmaceuticals
Abbott
Anthera Pharmaceuticals
Arcturus Therapeutics
Boehringer Ingelheim
Chiesi Farmaceutici
Corbus Pharmaceuticals
Genzyme
Insmed
Johnson & Johnson
Merck Sharp & Dohme
Neovii Biotech
Novo Nordisk
PharmaSwiss
Pharmaxis
Proteostasis Therapeutics
PTC Therapeutics
United Medical
Venus Remedies

In view of regional level, this report covers
United States
Europe
China
Japan
Southeast Asia
India

Segment by Type
Oral
Injection

Segment by Application
Hospitals
Clinics
Other


Table of Contents

    Global Cystic Fibrosis Drugs Sales Market Report 2019

      1 Cystic Fibrosis Drugs Market Overview

      • 1.1 Cystic Fibrosis DrugsProduct Overview
      • 1.2 Cystic Fibrosis Drugs Segment by Type
        • 1.2.1 Global Cystic Fibrosis Drugs Sales Comparison by Types (2014-2025)
        • 1.2.2 Oral
        • 1.2.3 Injection
      • 1.3 Cystic Fibrosis Drugs Segment by Application
        • 1.3.1 Global Cystic Fibrosis Drugs Sales Comparison by Application (2014-2025)
        • 1.3.1 Hospitals
        • 1.3.2 Clinics
        • 1.3.3 Other
      • 1.4 Cystic Fibrosis Drugs Market by Region
        • 1.4.1 Global Cystic Fibrosis Drugs Revenue Comparison by Region (2014-2025)
        • 1.4.2 United States Cystic Fibrosis Drugs Status and Prospect (2014-2025)
        • 1.4.3 Europe Cystic Fibrosis Drugs Status and Prospect (2014-2025)
        • 1.4.4 China Cystic Fibrosis Drugs Status and Prospect (2014-2025)
        • 1.4.5 Japan Cystic Fibrosis Drugs Status and Prospect (2014-2025)
        • 1.4.6 Southeast Asia Cystic Fibrosis Drugs Status and Prospect (2014-2025)
        • 1.4.7 India Cystic Fibrosis Drugs Status and Prospect (2014-2025)
      • 1.5 Global Cystic Fibrosis Drugs Sales and Revenue (2014-2025)
        • 1.5.1 Global Cystic Fibrosis Drugs Sales and Growth Rate (2014-2025)
        • 1.5.2 Global Cystic Fibrosis Drugs Revenue and Growth Rate (2014-2025)

      2 Cystic Fibrosis Drugs by Company, Region, Type and Application

      • 2.1 Global Cystic Fibrosis Drugs Market Competition by Companies
        • 2.1.1 Global Cystic Fibrosis Drugs Sales Market Share of Key Companies (2014-2019)
        • 2.1.2 Global Cystic Fibrosis Drugs Revenue Market Share by Company (2014-2019)
      • 2.2 Global Cystic Fibrosis Drugs Sales and Revenue by Region
        • 2.2.1 Global Cystic Fibrosis Drugs Sales Market Share by Region (2014-2019)
        • 2.2.2 Global Cystic Fibrosis Drugs Revenue Market Share by Region (2014-2019)
      • 2.3 Global Cystic Fibrosis Drugs Sales and Revenue by Type
        • 2.3.1 Global Cystic Fibrosis Drugs Sales Market Share by Type (2014-2019)
        • 2.3.2 Global Cystic Fibrosis Drugs Revenue Market Share by Type (2014-2019)
      • 2.4 Global Cystic Fibrosis Drugs Sales by Application

      3 United States Cystic Fibrosis Drugs Sales, Revenue and Price

      • 3.1 United States Cystic Fibrosis Drugs Sales and Revenue (2014-2019)
        • 3.1.1 United States Cystic Fibrosis Drugs Sales Growth Rate (2014-2019)
        • 3.1.2 United States Cystic Fibrosis Drugs Revenue Growth Rate (2014-2019)
        • 3.1.3 United States Cystic Fibrosis Drugs Price Trend (2014-2019)
      • 3.2 United States Cystic Fibrosis Drugs Sales Market Share by Company
      • 3.3 United States Cystic Fibrosis Drugs Sales Market Share by Type
      • 3.4 United States Cystic Fibrosis Drugs Sales Market Share by Application

      4 Europe Cystic Fibrosis Drugs Sales, Revenue and Price

      • 4.1 Europe Cystic Fibrosis Drugs Sales and Value (2014-2019)
        • 4.1.1 Europe Cystic Fibrosis Drugs Sales Growth Rate (2014-2019)
        • 4.1.2 Europe Cystic Fibrosis Drugs Revenue Growth Rate (2014-2019)
        • 4.1.3 Europe Cystic Fibrosis Drugs Price Trend (2014-2019)
      • 4.2 Europe Cystic Fibrosis Drugs Sales Market Share by Company
      • 4.3 Europe Cystic Fibrosis Drugs Sales Market Share by Type
      • 4.4 Europe Cystic Fibrosis Drugs Sales Market Share by Application

      5 China Cystic Fibrosis Drugs Sales, Revenue and Price

      • 5.1 China Cystic Fibrosis Drugs Sales and Revenue (2014-2019)
        • 5.1.1 China Cystic Fibrosis Drugs Sales Growth Rate (2014-2019)
        • 5.1.2 China Cystic Fibrosis Drugs Revenue Growth Rate (2014-2019)
        • 5.1.3 China Cystic Fibrosis Drugs Price Trend (2014-2019)
      • 5.2 China Cystic Fibrosis Drugs Sales Market Share by Company
      • 5.3 China Cystic Fibrosis Drugs Sales Market Share by Type
      • 5.4 China Cystic Fibrosis Drugs Sales Market Share by Application

      6 Japan Cystic Fibrosis Drugs Sales, Revenue and Price

      • 6.1 Japan Cystic Fibrosis Drugs Sales and Value (2014-2019)
        • 6.1.1 Japan Cystic Fibrosis Drugs Sales Growth Rate (2014-2019)
        • 6.1.2 Japan Cystic Fibrosis Drugs Revenue Growth Rate (2014-2019)
        • 6.1.3 Japan Cystic Fibrosis Drugs Price Trend (2014-2019)
      • 6.2 Japan Cystic Fibrosis Drugs Sales Market Share by Company
      • 6.3 Japan Cystic Fibrosis Drugs Sales Market Share by Type
      • 6.4 Japan Cystic Fibrosis Drugs Sales Market Share by Application

      7 Southeast Asia Cystic Fibrosis Drugs Sales, Revenue and Price

      • 7.1 Southeast Asia Cystic Fibrosis Drugs Sales and Value (2014-2019)
        • 7.1.1 Southeast Asia Cystic Fibrosis Drugs Sales Growth Rate (2014-2019)
        • 7.1.2 Southeast Asia Cystic Fibrosis Drugs Revenue Growth Rate (2014-2019)
        • 7.1.3 Southeast Asia Cystic Fibrosis Drugs Price Trend (2014-2019)
      • 7.2 Southeast Asia Cystic Fibrosis Drugs Sales Market Share by Company
      • 7.3 Southeast Asia Cystic Fibrosis Drugs Sales Market Share by Type
      • 7.4 Southeast Asia Cystic Fibrosis Drugs Sales Market Share by Application

      8 India Cystic Fibrosis Drugs Sales, Revenue and Price

      • 8.1 India Cystic Fibrosis Drugs Sales and Value (2014-2019)
        • 8.1.1 India Cystic Fibrosis Drugs Sales Growth Rate (2014-2019)
        • 8.1.2 India Cystic Fibrosis Drugs Revenue Growth Rate (2014-2019)
        • 8.1.3 India Cystic Fibrosis Drugs Price Trend (2014-2019)
      • 8.2 India Cystic Fibrosis Drugs Sales Market Share by Company
      • 8.3 India Cystic Fibrosis Drugs Sales Market Share by Type
      • 8.4 India Cystic Fibrosis Drugs Sales Market Share by Application

      9 Company Profiles and Key Figures in Cystic Fibrosis Drugs Business

      • 9.1 Actavis
        • 9.1.1 Actavis Cystic Fibrosis Drugs Production Sites and Area Served
        • 9.1.2 Cystic Fibrosis Drugs Specification and Application
        • 9.1.3 Actavis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.1.4 Main Business and Markets Served
      • 9.2 F. Hoffmann-La Roche
        • 9.2.1 F. Hoffmann-La Roche Cystic Fibrosis Drugs Production Sites and Area Served
        • 9.2.2 Cystic Fibrosis Drugs Specification and Application
        • 9.2.3 F. Hoffmann-La Roche Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.2.4 Main Business and Markets Served
      • 9.3 Gilead Sciences
        • 9.3.1 Gilead Sciences Cystic Fibrosis Drugs Production Sites and Area Served
        • 9.3.2 Cystic Fibrosis Drugs Specification and Application
        • 9.3.3 Gilead Sciences Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.3.4 Main Business and Markets Served
      • 9.4 Novartis
        • 9.4.1 Novartis Cystic Fibrosis Drugs Production Sites and Area Served
        • 9.4.2 Cystic Fibrosis Drugs Specification and Application
        • 9.4.3 Novartis Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.4.4 Main Business and Markets Served
      • 9.5 Vertex Pharmaceuticals
        • 9.5.1 Vertex Pharmaceuticals Cystic Fibrosis Drugs Production Sites and Area Served
        • 9.5.2 Cystic Fibrosis Drugs Specification and Application
        • 9.5.3 Vertex Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.5.4 Main Business and Markets Served
      • 9.6 Abbott
        • 9.6.1 Abbott Cystic Fibrosis Drugs Production Sites and Area Served
        • 9.6.2 Cystic Fibrosis Drugs Specification and Application
        • 9.6.3 Abbott Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.6.4 Main Business and Markets Served
      • 9.7 Anthera Pharmaceuticals
        • 9.7.1 Anthera Pharmaceuticals Production Sites and Area Served
        • 9.7.2 Cystic Fibrosis Drugs Specification and Application
        • 9.7.3 Anthera Pharmaceuticals Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.7.4 Main Business and Markets Served
      • 9.8 Arcturus Therapeutics
        • 9.8.1 Arcturus Therapeutics Cystic Fibrosis Drugs Production Sites and Area Served
        • 9.8.2 Cystic Fibrosis Drugs Specification and Application
        • 9.8.3 Arcturus Therapeutics Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.8.4 Main Business and Markets Served
      • 9.9 Boehringer Ingelheim
        • 9.9.1 Boehringer Ingelheim Cystic Fibrosis Drugs Production Sites and Area Served
        • 9.9.2 Cystic Fibrosis Drugs Specification and Application
        • 9.9.3 Boehringer Ingelheim Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.9.4 Main Business and Markets Served
      • 9.10 Chiesi Farmaceutici
        • 9.10.1 Chiesi Farmaceutici Cystic Fibrosis Drugs Production Sites and Area Served
        • 9.10.2 Cystic Fibrosis Drugs Specification and Application
        • 9.10.3 Chiesi Farmaceutici Cystic Fibrosis Drugs Sales, Revenue, Price and Gross Margin (2014-2019)
        • 9.10.4 Main Business and Markets Served
      • 9.11 Corbus Pharmaceuticals
      • 9.12 Genzyme
      • 9.13 Insmed
      • 9.14 Johnson & Johnson
      • 9.15 Merck Sharp & Dohme
      • 9.16 Neovii Biotech
      • 9.17 Novo Nordisk
      • 9.18 PharmaSwiss
      • 9.19 Pharmaxis
      • 9.20 Proteostasis Therapeutics
      • 9.21 PTC Therapeutics
      • 9.22 United Medical
      • 9.23 Venus Remedies

      10 Cystic Fibrosis Drugs Maufacturing Cost Analysis

      • 10.1 Cystic Fibrosis Drugs Key Raw Materials Analysis
        • 10.1.1 Key Raw Materials
        • 10.1.2 Key Raw Materials Price Trend
        • 10.1.3 Key Suppliers of Raw Materials
      • 10.2 Proportion of Manufacturing Cost Structure
      • 10.3 Manufacturing Process Analysis of Cystic Fibrosis Drugs
      • 10.4 Cystic Fibrosis Drugs Industrial Chain Analysis

      11 Marketing Channel, Distributors and Customers

      • 11.1 Marketing Channel
        • 11.1.1 Direct Marketing
        • 11.1.2 Indirect Marketing
      • 11.2 Cystic Fibrosis Drugs Distributors List
      • 11.3 Cystic Fibrosis Drugs Customers

      12 Market Dynamics

      • 12.1 Market Trends
      • 12.2 Opportunities
      • 12.3 Market Drivers
      • 12.4 Challenges
      • 12.5 Influence Factors

      13 Cystic Fibrosis Drugs Market Forecast

      • 13.1 Global Cystic Fibrosis Drugs Sales, Revenue and Price Forecast
        • 13.1.1 Global Cystic Fibrosis Drugs Sales Growth Forecast (2019-2025)
        • 13.1.2 Global Cystic Fibrosis Drugs Revenue Growth Forecast (2019-2025)
        • 13.1.3 Global Cystic Fibrosis Drugs Price Trend Forecast (2019-2025)
      • 13.2 Global Cystic Fibrosis Drugs Forecast by Region
        • 13.2.1 Global Cystic Fibrosis Drugs Sales Growth Forecast by Region (2019-2025)
        • 13.2.2 Global Cystic Fibrosis Drugs Revenue Growth Forecast by Region (2019-2025)
        • 13.2.3 United States Cystic Fibrosis Drugs Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.4 Europe Cystic Fibrosis Drugs Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.5 China Cystic Fibrosis Drugs Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.6 Japan Cystic Fibrosis Drugs Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.7 Southeast Asia Cystic Fibrosis Drugs Sales, Revenue Growth Forecast (2019-2025)
        • 13.2.8 India Cystic Fibrosis Drugs Sales, Revenue Growth Forecast (2019-2025)
      • 13.3 Global Cystic Fibrosis Drugs Forecast by Type
        • 13.3.1 Global Cystic Fibrosis Drugs Sales Forecast by Type (2019-2025)
        • 13.3.2 Global Cystic Fibrosis Drugs Revenue Forecast by Type (2019-2025)
        • 13.3.3 Global Cystic Fibrosis Drugs Price Forecast by Type (2019-2025)
      • 13.4 Global Cystic Fibrosis Drugs Forecast by Application

      14 Research Findings and Conclusion

        15 Methodology and Data Source

        • 15.1 Methodology/Research Approach
          • 15.1.1 Research Programs/Design
          • 15.1.2 Market Size Estimation
          • 15.1.3 Market Breakdown and Data Triangulation
        • 15.2 Data Source
          • 15.2.1 Secondary Sources
          • 15.2.2 Primary Sources
        • 15.3 Author List

        Summary:
        Get latest Market Research Reports on Cystic Fibrosis Drugs. Industry analysis & Market Report on Cystic Fibrosis Drugs is a syndicated market report, published as Global Cystic Fibrosis Drugs Sales Market Report 2019. It is complete Research Study and Industry Analysis of Cystic Fibrosis Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $4,000.00
        $6,000.00
        $8,000.00
        3,136.00
        4,704.00
        6,272.00
        3,692.00
        5,538.00
        7,384.00
        625,320.00
        937,980.00
        1,250,640.00
        333,960.00
        500,940.00
        667,920.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report